Free tool
Oncology stocks
We cover 111 companies grouped under the Oncology theme. The median market value in the group is $455.62M. Across the group, the median move over the past trading day is +1.85%. 56% of the 107 with a 200-day average trade above it. Price change over the past year runs from −58.3% to +187.8% across the middle 80 percent of the group, with a median of +9.2%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
111 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% | Oct 29, 2026 |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% | Oct 27, 2026 |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% | Nov 4, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% | Nov 5, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% | Oct 30, 2026 |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% | Nov 3, 2026 |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% | Oct 27, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% | Nov 5, 2026 |
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% | Nov 5, 2026 |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.55% | Oct 27, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% | Oct 27, 2026 |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +44.33% | Oct 27, 2026 |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% | Oct 19, 2026 |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% | Nov 5, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% | Nov 5, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% | Nov 12, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% | Nov 2, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% | Nov 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% | Nov 16, 2026 |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% | Nov 12, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% | Nov 5, 2026 |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% | Nov 17, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% | Nov 5, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% | Nov 3, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% | Nov 13, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% | Nov 5, 2026 |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% | Nov 3, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% | Nov 4, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% | Nov 12, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% | Nov 9, 2026 |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% | Nov 11, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% | Nov 3, 2026 |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% | Nov 12, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% | Nov 3, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% | Nov 11, 2026 |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% | Nov 12, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% | Nov 5, 2026 |
| GUD.TO | Knight Therapeutics Inc. | $692.32M | Small cap | +49.08% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% | Nov 12, 2026 |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +346.30% | Sep 29, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −21.16% | Nov 3, 2026 |
| SGMT | Sagimet Biosciences Inc. | $639.61M | Small cap | +45.34% | Nov 12, 2026 |
| ARVN | Arvinas, Inc. | $610.71M | Small cap | +28.34% | Nov 4, 2026 |
| DCTH | Delcath Systems, Inc. | $587.10M | Small cap | +55.37% | Nov 3, 2026 |
| 0KCS.L | OPKO Health, Inc. | $578.38M | Small cap | +5.63% | Oct 28, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $516.71M | Small cap | +66.01% | Nov 5, 2026 |
| 0IL8.L | Kyntra Bio, Inc. | $512.46M | Small cap | −24.41% | Nov 9, 2026 |
| PBYI | Puma Biotechnology, Inc. | $470.77M | Small cap | +86.77% | Nov 5, 2026 |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −21.47% | Nov 3, 2026 |
| CMPX | Compass Therapeutics, Inc. | $455.62M | Small cap | −16.23% | Nov 5, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $410.64M | Small cap | +35.38% | Nov 12, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $406.79M | Small cap | +30.48% | Nov 5, 2026 |
| PRTC.L | PureTech Health plc | $402.61M | Small cap | −11.34% | Aug 27, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | $392.65M | Small cap | +27.38% | Nov 12, 2026 |
| AGEN | Agenus Inc. | $376.28M | Small cap | +90.43% | Nov 5, 2026 |
| CATX | Perspective Therapeutics, Inc. | $375.56M | Small cap | −4.91% | Nov 9, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.32% | Nov 5, 2026 |
| BCYC | Bicycle Therapeutics plc | $306.47M | Small cap | −38.34% | Oct 29, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $278.20M | Small cap | +198.82% | Nov 5, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $276.55M | Small cap | +81.82% | Nov 6, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $265.63M | Small cap | +154.27% | Nov 12, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $258.04M | Small cap | +56.35% | Nov 12, 2026 |
| 0IV3.L | Geron Corporation | $255.34M | Small cap | +8.41% | Nov 4, 2026 |
| PYXS | Pyxis Oncology, Inc. | $255.23M | Small cap | +120.14% | Nov 2, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.95M | Small cap | +1.84% | Sep 17, 2026 |
| TARA | Protara Therapeutics, Inc. | $234.61M | Small cap | +30.16% | Nov 10, 2026 |
| CHRS | Coherus Oncology, Inc. | $211.67M | Small cap | +17.09% | Nov 5, 2026 |
| BINV.ST | BioInvent International AB (publ) | $169.15M | Small cap | −24.30% | Aug 27, 2026 |
| 0IMT.L | Photocure ASA | $144.18M | Small cap | −12.59% | Oct 28, 2026 |
| ADCT | ADC Therapeutics SA | $132.77M | Small cap | −66.34% | Nov 10, 2026 |
| HURA | TuHURA Biosciences, Inc. | $130.00M | Small cap | −30.85% | Nov 13, 2026 |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +5951.72% | Aug 27, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $123.81M | Small cap | −21.95% | Nov 5, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −18.72% | Nov 12, 2026 |
| HBP.TO | Helix BioPharma Corp. | $109.87M | Small cap | +35.37% | Oct 29, 2026 |
| ONCY | Oncolytics Biotech Inc. | $109.84M | Small cap | −12.99% | Nov 16, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% | Sep 28, 2026 |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −76.73% | Nov 3, 2026 |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% | Nov 12, 2026 |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% | Nov 16, 2026 |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% | Nov 5, 2026 |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% | Nov 16, 2026 |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% | Nov 3, 2026 |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% | Sep 2, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.92% | Sep 28, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% | Oct 30, 2026 |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $42.19M | Micro cap | −69.57% | Nov 3, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% | Nov 9, 2026 |
| 4582.T | SymBio Pharmaceuticals Limited | $31.73M | Micro cap | −58.28% | Oct 29, 2026 |
| BYSI | BeyondSpring Inc. | $29.61M | Micro cap | −60.43% | Nov 12, 2026 |
| MDNA.TO | Medicenna Therapeutics Corp. | $29.00M | Micro cap | −58.77% | Nov 12, 2026 |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −52.30% | Nov 11, 2026 |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −45.96% | Nov 12, 2026 |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% | Nov 11, 2026 |
| TPST | Tempest Therapeutics, Inc. | $18.36M | Micro cap | −89.50% | Nov 5, 2026 |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −31.23% | Nov 5, 2026 |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% | Aug 31, 2026 |
| PDSB | PDS Biotechnology Corporation | $12.40M | Micro cap | −82.96% | Nov 12, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% | Sep 28, 2026 |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +3.85% | Nov 5, 2026 |
| BCAB | BioAtla, Inc. | $5.43M | Micro cap | −81.69% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −3.64% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.